Works matching IS 22490159 AND DT 2016 AND VI 6 AND IP 4
Results: 6
An upscaled extraction protocol for Tasmannia lanceolata (Poir.) A.C. Sm.: Anti-bacterial, anti-Giardial and anticancer activity.
- Published in:
- Pharmacognosy Communications, 2016, v. 6, n. 4, p. 238, doi. 10.5530/pc.2016.4.7
- By:
- Publication type:
- Article
High-Throughput Screening by In silico Molecular Docking of Eryngium Foetidum (Linn.) Bioactives for Cylcooxygenase-2 Inhibition.
- Published in:
- Pharmacognosy Communications, 2016, v. 6, n. 4, p. 232, doi. 10.5530/pc.2016.4.6
- By:
- Publication type:
- Article
Metabolite profiling by UPLC-PDA-ESI/HDMS and antibacterial activity of Memecylon talbotianum Brandis.
- Published in:
- Pharmacognosy Communications, 2016, v. 6, n. 4, p. 225, doi. 10.5530/pc.2016.4.5
- By:
- Publication type:
- Article
Growth inhibitory properties of extracts prepared from selected Leptospermum and Melaleuca species against a panel of pathogenic bacteria.
- Published in:
- Pharmacognosy Communications, 2016, v. 6, n. 4, p. 215, doi. 10.5530/pc.2016.4.4
- By:
- Publication type:
- Article
Acai, cacao and maca extracts: Anticancer activity and growth inhibition of microbial triggers of selected autoimmune inflammatory diseases.
- Published in:
- Pharmacognosy Communications, 2016, v. 6, n. 4, p. 204, doi. 10.5530/pc.2016.4.3
- By:
- Publication type:
- Article
Growth inhibitory properties of Backhousia myrtifolia Hook. & Harv. and Syzygium anisatum (Vickery) Craven & Biffen extracts against a panel of pathogenic bacteria.
- Published in:
- Pharmacognosy Communications, 2016, v. 6, n. 4, p. 194, doi. 10.5530/pc.2016.4.2
- By:
- Publication type:
- Article